181 related articles for article (PubMed ID: 21739269)
41. Expression of cell cycle regulatory proteins in eyelid sebaceous gland carcinoma: low p27 expression predicts poor prognosis.
Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
Exp Eye Res; 2014 Jan; 118():46-52. PubMed ID: 24216315
[TBL] [Abstract][Full Text] [Related]
42. Immunoexpression of beta-catenin--E-cadherin complex in primary serous ovarian tumors.
Stawerski P; Wagrowska-Danilewicz M; Stasikowska O; Gottwald L; Danilewicz M
Pol J Pathol; 2008; 59(1):27-32. PubMed ID: 18655368
[TBL] [Abstract][Full Text] [Related]
43. miRNA-200c and miRNA-141 as potential prognostic biomarkers and regulators of epithelial-mesenchymal transition in eyelid sebaceous gland carcinoma.
Bhardwaj M; Sen S; Chosdol K; Sharma A; Pushker N; Kashyap S; Bakhshi S; Bajaj MS
Br J Ophthalmol; 2017 Apr; 101(4):536-542. PubMed ID: 28119291
[TBL] [Abstract][Full Text] [Related]
44. Expression of Shh and Wnt signaling pathway proteins in eyelid sebaceous gland carcinoma: clinicopathologic study.
Kim N; Kim JE; Choung HK; Lee MJ; Khwarg SI
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):370-7. PubMed ID: 23249701
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of cell-adhesion molecules in histological variants of papillary thyroid carcinoma.
Andriescu EC; Căruntu ID; Giuşcă SE; Lozneanu L; Ciobanu Apostol DG
Rom J Morphol Embryol; 2018; 59(3):721-727. PubMed ID: 30534810
[TBL] [Abstract][Full Text] [Related]
46. Investigation of β-catenin and E-cadherin expression in Dukes B2 stage colorectal cancer with tissue microarray method. Is it a marker of metastatic potential in rectal cancer?
Tóth L; András C; Molnár C; Tanyi M; Csiki Z; Molnár P; Szántó J
Pathol Oncol Res; 2012 Apr; 18(2):429-37. PubMed ID: 21975680
[TBL] [Abstract][Full Text] [Related]
47. Expression of E-cadherin, beta-catenin and Ki-67 antigen and their reciprocal relationships in mammary adenocarcinomas in bitches.
Nowak M; Madej JA; Dziegiel P
Folia Histochem Cytobiol; 2007; 45(3):233-8. PubMed ID: 17951173
[TBL] [Abstract][Full Text] [Related]
48. Expression of mismatch repair proteins, beta catenin, and E cadherin in intestinal-type sinonasal adenocarcinoma.
Perez-Ordonez B; Huynh NN; Berean KW; Jordan RC
J Clin Pathol; 2004 Oct; 57(10):1080-3. PubMed ID: 15452164
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
Ozgüven BY; Karaçetin D; Kabukçuoğlu F; Taşkin T; Yener Ş
Pol J Pathol; 2011; 62(1):19-24. PubMed ID: 21574102
[TBL] [Abstract][Full Text] [Related]
50. Expression and localization of E-cadherin and β-catenin in uterine carcinosarcoma.
Nishimura I; Ohishi Y; Oda Y; Kishimoto J; Yasunaga M; Okuma E; Kobayashi H; Wake N; Tsuneyoshi M
Virchows Arch; 2011 Jan; 458(1):85-94. PubMed ID: 21046151
[TBL] [Abstract][Full Text] [Related]
51. Sebaceous gland carcinoma of the eyelid presenting as a conjunctival papilloma.
Miyagawa M; Hayasaka S; Nagaoka S; Mihara M
Ophthalmologica; 1994; 208(1):46-8. PubMed ID: 8145986
[TBL] [Abstract][Full Text] [Related]
52. Aberrant distributions and relationships among E-cadherin, beta-catenin, and connexin 26 and 43 in endometrioid adenocarcinomas.
Wincewicz A; Baltaziak M; Kanczuga-Koda L; Lesniewicz T; Rutkowski R; Sobaniec-Lotowska M; Sulkowski S; Koda M; Sulkowska M
Int J Gynecol Pathol; 2010 Jul; 29(4):358-65. PubMed ID: 20567150
[TBL] [Abstract][Full Text] [Related]
53. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival.
Zhou YN; Xu CP; Han B; Li M; Qiao L; Fang DC; Yang JM
World J Gastroenterol; 2002 Dec; 8(6):987-93. PubMed ID: 12439911
[TBL] [Abstract][Full Text] [Related]
54. Alteration of the E-cadherin/β-catenin complex predicts poor response to epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment.
Yoo SB; Kim YJ; Kim H; Jin Y; Sun PL; Jheon S; Lee JS; Chung JH
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S545-52. PubMed ID: 23579873
[TBL] [Abstract][Full Text] [Related]
55. Aberrant expression of nuclear vimentin and related epithelial-mesenchymal transition markers in nasopharyngeal carcinoma.
Luo W; Fang W; Li S; Yao K
Int J Cancer; 2012 Oct; 131(8):1863-73. PubMed ID: 22307379
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma.
Zaid KW
Asian Pac J Cancer Prev; 2014; 15(20):8847-53. PubMed ID: 25374218
[TBL] [Abstract][Full Text] [Related]
57. Sebaceous cell carcinoma of the eyelid: a rapidly enlarging lesion with massive xanthogranulomatous inflammation.
Hwang FS; Neekhra A; Lucarelli MJ; Warner TF; Snow SN; Albert DM
Ophthalmic Plast Reconstr Surg; 2010; 26(3):208-10. PubMed ID: 20489549
[TBL] [Abstract][Full Text] [Related]
58. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.
Rajan Kd A; Burris C; Iliff N; Grant M; Eshleman JR; Eberhart CG
Am J Ophthalmol; 2014 Mar; 157(3):640-7.e1-2. PubMed ID: 24321472
[TBL] [Abstract][Full Text] [Related]
59. Investigation of N-cadherin/β-catenin expression in adrenocortical tumors.
Rubin B; Regazzo D; Redaelli M; Mucignat C; Citton M; Iacobone M; Scaroni C; Betterle C; Mantero F; Fassina A; Pezzani R; Boscaro M
Tumour Biol; 2016 Oct; 37(10):13545-13555. PubMed ID: 27468715
[TBL] [Abstract][Full Text] [Related]
60. Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer.
Pirinen RT; Hirvikoski P; Johansson RT; Hollmén S; Kosma VM
J Clin Pathol; 2001 May; 54(5):391-5. PubMed ID: 11328840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
